TerrAscend (TSNDF) versus Its Peers Critical Contrast

TerrAscend (OTCMKTS:TSNDFGet Free Report) is one of 43 publicly-traded companies in the “Agricultural production – crops” industry, but how does it weigh in compared to its peers? We will compare TerrAscend to similar businesses based on the strength of its risk, valuation, institutional ownership, profitability, earnings, dividends and analyst recommendations.

Risk & Volatility

TerrAscend has a beta of 1.64, indicating that its stock price is 64% more volatile than the S&P 500. Comparatively, TerrAscend’s peers have a beta of -19.60, indicating that their average stock price is 2,060% less volatile than the S&P 500.

Profitability

This table compares TerrAscend and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
TerrAscend -23.95% -31.48% -11.40%
TerrAscend Competitors -98.15% -2,439.03% -14.56%

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for TerrAscend and its peers, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
TerrAscend 0 1 0 1 3.00
TerrAscend Competitors 319 261 606 34 2.29

As a group, “Agricultural production – crops” companies have a potential upside of 51.72%. Given TerrAscend’s peers higher possible upside, analysts plainly believe TerrAscend has less favorable growth aspects than its peers.

Insider & Institutional Ownership

5.8% of TerrAscend shares are owned by institutional investors. Comparatively, 20.7% of shares of all “Agricultural production – crops” companies are owned by institutional investors. 31.9% of TerrAscend shares are owned by insiders. Comparatively, 16.0% of shares of all “Agricultural production – crops” companies are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Valuation and Earnings

This table compares TerrAscend and its peers gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
TerrAscend $317.33 million -$95.54 million -1.64
TerrAscend Competitors $1.23 billion -$827,419.35 7.05

TerrAscend’s peers have higher revenue and earnings than TerrAscend. TerrAscend is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Summary

TerrAscend beats its peers on 7 of the 13 factors compared.

About TerrAscend

(Get Free Report)

TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. The company produces and distributes hemp-derived wellness products to retail locations; and manufactures vaporizables, concentrates, topicals, tinctures and edibles. It also operates retail dispensaries under the Apothecarium and State Flower brand names. The company was incorporated in 2017 and is headquartered in Mississauga, Canada.

Receive News & Ratings for TerrAscend Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TerrAscend and related companies with MarketBeat.com's FREE daily email newsletter.